Mecanismos subjacentes à coinfecção entre COVID-19 e síndrome de Guillain-Barré: Susceptibilidade, progressão da doença e impacto clínico – Uma revisão sistemática
Objective: To analyze the complex synergistic interaction between Covid-19 and Guillain-Barré Syndrome (GBS), exploring the clinical and epidemiological implications of this co-infection. It also seeks to evaluate the diagnostic and therapeutic challenges faced by co-infected patients and to discuss...
Gespeichert in:
Veröffentlicht in: | Lumen et virtus 2024-09, Vol.15 (39), p.4091-4101 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | por |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4101 |
---|---|
container_issue | 39 |
container_start_page | 4091 |
container_title | Lumen et virtus |
container_volume | 15 |
creator | Milani, Bruno Henrique Marcelino, Mirella Montandon Oliveira, Laís Maria de Sousa Leite, Laura Souza Forti, Maria Júlia Faria Bernardes, Amanda Matos Martins De Carvalho, Marina Borges Lopes Melo, Victor Hugo Mundim Calais, Rafael Costa Bicalho, Ruan Júnio Lopes |
description | Objective: To analyze the complex synergistic interaction between Covid-19 and Guillain-Barré Syndrome (GBS), exploring the clinical and epidemiological implications of this co-infection. It also seeks to evaluate the diagnostic and therapeutic challenges faced by co-infected patients and to discuss public health strategies. Methodology: It is a systematic review focused on understanding the main aspects of Covid-19 co-infection and Guillain-Barré Syndrome (GBS). The research was guided by the question: 'What are the biological and immunological mechanisms underlying the interaction between SARS-CoV-2 and GBS and how do they affect susceptibility, disease progression and clinical manifestations of patients?'. To find answers, we searched the PubMed database using four descriptors combined with the Boolean term "AND": Guillain-Barre Syndrome, COVID-19, SARS-CoV-2, and COVID-19 Vaccines. This resulted in 562 articles. 14 articles were selected for analysis. Results: The reviewed evidence shows a significant association between COVID-19 and the development of Guillain-Barré Syndrome (GBS), especially in older men. The pathogenesis suggests that the inflammatory response triggered by COVID-19 may contribute to the emergence of GBS. The infection aggravates respiratory complications in patients with GBS, increasing the need for early ventilation. Immunomodulatory therapies, such as intravenous immunoglobulin (IVIg), are effective and safe in the management of these patients Conclusion:The review highlights the importance of early diagnosis and close clinical monitoring to improve outcomes.
Objetivo: Analisar a complexa interação sinérgica entre o Covid-19 e a Síndrome de Guillain-Barré (SGB), explorando as implicações clínicas e epidemiológicas dessa coinfecção. Busca-se também avaliar os desafios diagnósticos e terapêuticos enfrentados pelos pacientes co-infectados e discutir as estratégias de saúde pública. Metodologia: É uma revisão sistemática focada em entender os aspectos principais da coinfecção de Covid-19 e a Síndrome de Guillain-Barré (SGB). A pesquisa foi guiada pela pergunta: ‘Quais são os mecanismos biológicos e imunológicos subjacentes à interação entre SARS-CoV-2 e SGB e como eles afetam a susceptibilidade, progressão da doença e as manifestações clínicas dos doentes?’. Para encontrar respostas, foram realizadas buscas na base de dados PubMed usando quatro descritores combinados com o termo booleano “AND”:Guillain-Barre Syndrome, COVID-19, SARS- |
doi_str_mv | 10.56238/levv15n39-191 |
format | Article |
fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_56238_levv15n39_191</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_56238_levv15n39_191</sourcerecordid><originalsourceid>FETCH-LOGICAL-c791-d0a286b928a70d95eebb1f3917b71a15de772031acd9ef53a593cb1ed60753823</originalsourceid><addsrcrecordid>eNpNkMFKw0AQhoMoWGqvnvcBTN3NkmzWm1athUoPVq9hsjuRLUm27KYFb76DL6B4KB7Eh8ib-CTGKuJc_mEYvh--IDhkdBgnEU-PS1yvWVxzGTLJdoJexIQII5HK3X_7fjDwfkG7SWgsGO0FH9eooDa-sp74Vb4AhXWDnrTPRFlTF6jaTftqSXd1SEazu8l5V0CQ-Pa91s5WSDSS8cqUJZg6PAPn2rcTcrPyCpeNyU1pNGg8Iktn7x16_w3TQLTFut1ABzLVElRjiSo7olGWfD4-kdsKiMO12b574xus2pfGKDgI9gooPQ5-sx_MLy_mo6twOhtPRqfTUAnJQk0hSpNcRikIqmWMmOes4JKJXDBgsUYhIsoZKC2xiDnEkqucoU6oiHka8X4w_MEqZ713WGRLZypwDxmj2VZ49ic864TzL0dGfwA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Mecanismos subjacentes à coinfecção entre COVID-19 e síndrome de Guillain-Barré: Susceptibilidade, progressão da doença e impacto clínico – Uma revisão sistemática</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Milani, Bruno Henrique ; Marcelino, Mirella Montandon ; Oliveira, Laís Maria de Sousa ; Leite, Laura Souza ; Forti, Maria Júlia Faria ; Bernardes, Amanda Matos Martins ; De Carvalho, Marina Borges Lopes ; Melo, Victor Hugo Mundim ; Calais, Rafael Costa ; Bicalho, Ruan Júnio Lopes</creator><creatorcontrib>Milani, Bruno Henrique ; Marcelino, Mirella Montandon ; Oliveira, Laís Maria de Sousa ; Leite, Laura Souza ; Forti, Maria Júlia Faria ; Bernardes, Amanda Matos Martins ; De Carvalho, Marina Borges Lopes ; Melo, Victor Hugo Mundim ; Calais, Rafael Costa ; Bicalho, Ruan Júnio Lopes</creatorcontrib><description>Objective: To analyze the complex synergistic interaction between Covid-19 and Guillain-Barré Syndrome (GBS), exploring the clinical and epidemiological implications of this co-infection. It also seeks to evaluate the diagnostic and therapeutic challenges faced by co-infected patients and to discuss public health strategies. Methodology: It is a systematic review focused on understanding the main aspects of Covid-19 co-infection and Guillain-Barré Syndrome (GBS). The research was guided by the question: 'What are the biological and immunological mechanisms underlying the interaction between SARS-CoV-2 and GBS and how do they affect susceptibility, disease progression and clinical manifestations of patients?'. To find answers, we searched the PubMed database using four descriptors combined with the Boolean term "AND": Guillain-Barre Syndrome, COVID-19, SARS-CoV-2, and COVID-19 Vaccines. This resulted in 562 articles. 14 articles were selected for analysis. Results: The reviewed evidence shows a significant association between COVID-19 and the development of Guillain-Barré Syndrome (GBS), especially in older men. The pathogenesis suggests that the inflammatory response triggered by COVID-19 may contribute to the emergence of GBS. The infection aggravates respiratory complications in patients with GBS, increasing the need for early ventilation. Immunomodulatory therapies, such as intravenous immunoglobulin (IVIg), are effective and safe in the management of these patients Conclusion:The review highlights the importance of early diagnosis and close clinical monitoring to improve outcomes.
Objetivo: Analisar a complexa interação sinérgica entre o Covid-19 e a Síndrome de Guillain-Barré (SGB), explorando as implicações clínicas e epidemiológicas dessa coinfecção. Busca-se também avaliar os desafios diagnósticos e terapêuticos enfrentados pelos pacientes co-infectados e discutir as estratégias de saúde pública. Metodologia: É uma revisão sistemática focada em entender os aspectos principais da coinfecção de Covid-19 e a Síndrome de Guillain-Barré (SGB). A pesquisa foi guiada pela pergunta: ‘Quais são os mecanismos biológicos e imunológicos subjacentes à interação entre SARS-CoV-2 e SGB e como eles afetam a susceptibilidade, progressão da doença e as manifestações clínicas dos doentes?’. Para encontrar respostas, foram realizadas buscas na base de dados PubMed usando quatro descritores combinados com o termo booleano “AND”:Guillain-Barre Syndrome, COVID-19, SARS-CoV-2 e COVID-19 Vaccines. Isso resultou em 562 artigos. Sendo selecionado 14 artigos para análise. Resultados: As evidências revisadas mostram uma associação significativa entre COVID-19 e o desenvolvimento da Síndrome de Guillain-Barré (SGB), especialmente em homens idosos. A patogênese sugere que a resposta inflamatória desencadeada pela COVID-19 pode contribuir para o surgimento da SGB. A infecção agrava as complicações respiratórias em pacientes com SGB, aumentando a necessidade de ventilação precoce. As terapias imunomoduladoras, como a imunoglobulina intravenosa (IVIg), são eficazes e seguras no manejo desses pacientes Conclusão:A revisão destaca a importância do diagnóstico precoce e do monitoramento clínico rigoroso para melhorar os desfechos.</description><identifier>ISSN: 2177-2789</identifier><identifier>EISSN: 2177-2789</identifier><identifier>DOI: 10.56238/levv15n39-191</identifier><language>por</language><ispartof>Lumen et virtus, 2024-09, Vol.15 (39), p.4091-4101</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Milani, Bruno Henrique</creatorcontrib><creatorcontrib>Marcelino, Mirella Montandon</creatorcontrib><creatorcontrib>Oliveira, Laís Maria de Sousa</creatorcontrib><creatorcontrib>Leite, Laura Souza</creatorcontrib><creatorcontrib>Forti, Maria Júlia Faria</creatorcontrib><creatorcontrib>Bernardes, Amanda Matos Martins</creatorcontrib><creatorcontrib>De Carvalho, Marina Borges Lopes</creatorcontrib><creatorcontrib>Melo, Victor Hugo Mundim</creatorcontrib><creatorcontrib>Calais, Rafael Costa</creatorcontrib><creatorcontrib>Bicalho, Ruan Júnio Lopes</creatorcontrib><title>Mecanismos subjacentes à coinfecção entre COVID-19 e síndrome de Guillain-Barré: Susceptibilidade, progressão da doença e impacto clínico – Uma revisão sistemática</title><title>Lumen et virtus</title><description>Objective: To analyze the complex synergistic interaction between Covid-19 and Guillain-Barré Syndrome (GBS), exploring the clinical and epidemiological implications of this co-infection. It also seeks to evaluate the diagnostic and therapeutic challenges faced by co-infected patients and to discuss public health strategies. Methodology: It is a systematic review focused on understanding the main aspects of Covid-19 co-infection and Guillain-Barré Syndrome (GBS). The research was guided by the question: 'What are the biological and immunological mechanisms underlying the interaction between SARS-CoV-2 and GBS and how do they affect susceptibility, disease progression and clinical manifestations of patients?'. To find answers, we searched the PubMed database using four descriptors combined with the Boolean term "AND": Guillain-Barre Syndrome, COVID-19, SARS-CoV-2, and COVID-19 Vaccines. This resulted in 562 articles. 14 articles were selected for analysis. Results: The reviewed evidence shows a significant association between COVID-19 and the development of Guillain-Barré Syndrome (GBS), especially in older men. The pathogenesis suggests that the inflammatory response triggered by COVID-19 may contribute to the emergence of GBS. The infection aggravates respiratory complications in patients with GBS, increasing the need for early ventilation. Immunomodulatory therapies, such as intravenous immunoglobulin (IVIg), are effective and safe in the management of these patients Conclusion:The review highlights the importance of early diagnosis and close clinical monitoring to improve outcomes.
Objetivo: Analisar a complexa interação sinérgica entre o Covid-19 e a Síndrome de Guillain-Barré (SGB), explorando as implicações clínicas e epidemiológicas dessa coinfecção. Busca-se também avaliar os desafios diagnósticos e terapêuticos enfrentados pelos pacientes co-infectados e discutir as estratégias de saúde pública. Metodologia: É uma revisão sistemática focada em entender os aspectos principais da coinfecção de Covid-19 e a Síndrome de Guillain-Barré (SGB). A pesquisa foi guiada pela pergunta: ‘Quais são os mecanismos biológicos e imunológicos subjacentes à interação entre SARS-CoV-2 e SGB e como eles afetam a susceptibilidade, progressão da doença e as manifestações clínicas dos doentes?’. Para encontrar respostas, foram realizadas buscas na base de dados PubMed usando quatro descritores combinados com o termo booleano “AND”:Guillain-Barre Syndrome, COVID-19, SARS-CoV-2 e COVID-19 Vaccines. Isso resultou em 562 artigos. Sendo selecionado 14 artigos para análise. Resultados: As evidências revisadas mostram uma associação significativa entre COVID-19 e o desenvolvimento da Síndrome de Guillain-Barré (SGB), especialmente em homens idosos. A patogênese sugere que a resposta inflamatória desencadeada pela COVID-19 pode contribuir para o surgimento da SGB. A infecção agrava as complicações respiratórias em pacientes com SGB, aumentando a necessidade de ventilação precoce. As terapias imunomoduladoras, como a imunoglobulina intravenosa (IVIg), são eficazes e seguras no manejo desses pacientes Conclusão:A revisão destaca a importância do diagnóstico precoce e do monitoramento clínico rigoroso para melhorar os desfechos.</description><issn>2177-2789</issn><issn>2177-2789</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpNkMFKw0AQhoMoWGqvnvcBTN3NkmzWm1athUoPVq9hsjuRLUm27KYFb76DL6B4KB7Eh8ib-CTGKuJc_mEYvh--IDhkdBgnEU-PS1yvWVxzGTLJdoJexIQII5HK3X_7fjDwfkG7SWgsGO0FH9eooDa-sp74Vb4AhXWDnrTPRFlTF6jaTftqSXd1SEazu8l5V0CQ-Pa91s5WSDSS8cqUJZg6PAPn2rcTcrPyCpeNyU1pNGg8Iktn7x16_w3TQLTFut1ABzLVElRjiSo7olGWfD4-kdsKiMO12b574xus2pfGKDgI9gooPQ5-sx_MLy_mo6twOhtPRqfTUAnJQk0hSpNcRikIqmWMmOes4JKJXDBgsUYhIsoZKC2xiDnEkqucoU6oiHka8X4w_MEqZ713WGRLZypwDxmj2VZ49ic864TzL0dGfwA</recordid><startdate>20240912</startdate><enddate>20240912</enddate><creator>Milani, Bruno Henrique</creator><creator>Marcelino, Mirella Montandon</creator><creator>Oliveira, Laís Maria de Sousa</creator><creator>Leite, Laura Souza</creator><creator>Forti, Maria Júlia Faria</creator><creator>Bernardes, Amanda Matos Martins</creator><creator>De Carvalho, Marina Borges Lopes</creator><creator>Melo, Victor Hugo Mundim</creator><creator>Calais, Rafael Costa</creator><creator>Bicalho, Ruan Júnio Lopes</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20240912</creationdate><title>Mecanismos subjacentes à coinfecção entre COVID-19 e síndrome de Guillain-Barré: Susceptibilidade, progressão da doença e impacto clínico – Uma revisão sistemática</title><author>Milani, Bruno Henrique ; Marcelino, Mirella Montandon ; Oliveira, Laís Maria de Sousa ; Leite, Laura Souza ; Forti, Maria Júlia Faria ; Bernardes, Amanda Matos Martins ; De Carvalho, Marina Borges Lopes ; Melo, Victor Hugo Mundim ; Calais, Rafael Costa ; Bicalho, Ruan Júnio Lopes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c791-d0a286b928a70d95eebb1f3917b71a15de772031acd9ef53a593cb1ed60753823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>por</language><creationdate>2024</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Milani, Bruno Henrique</creatorcontrib><creatorcontrib>Marcelino, Mirella Montandon</creatorcontrib><creatorcontrib>Oliveira, Laís Maria de Sousa</creatorcontrib><creatorcontrib>Leite, Laura Souza</creatorcontrib><creatorcontrib>Forti, Maria Júlia Faria</creatorcontrib><creatorcontrib>Bernardes, Amanda Matos Martins</creatorcontrib><creatorcontrib>De Carvalho, Marina Borges Lopes</creatorcontrib><creatorcontrib>Melo, Victor Hugo Mundim</creatorcontrib><creatorcontrib>Calais, Rafael Costa</creatorcontrib><creatorcontrib>Bicalho, Ruan Júnio Lopes</creatorcontrib><collection>CrossRef</collection><jtitle>Lumen et virtus</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Milani, Bruno Henrique</au><au>Marcelino, Mirella Montandon</au><au>Oliveira, Laís Maria de Sousa</au><au>Leite, Laura Souza</au><au>Forti, Maria Júlia Faria</au><au>Bernardes, Amanda Matos Martins</au><au>De Carvalho, Marina Borges Lopes</au><au>Melo, Victor Hugo Mundim</au><au>Calais, Rafael Costa</au><au>Bicalho, Ruan Júnio Lopes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mecanismos subjacentes à coinfecção entre COVID-19 e síndrome de Guillain-Barré: Susceptibilidade, progressão da doença e impacto clínico – Uma revisão sistemática</atitle><jtitle>Lumen et virtus</jtitle><date>2024-09-12</date><risdate>2024</risdate><volume>15</volume><issue>39</issue><spage>4091</spage><epage>4101</epage><pages>4091-4101</pages><issn>2177-2789</issn><eissn>2177-2789</eissn><abstract>Objective: To analyze the complex synergistic interaction between Covid-19 and Guillain-Barré Syndrome (GBS), exploring the clinical and epidemiological implications of this co-infection. It also seeks to evaluate the diagnostic and therapeutic challenges faced by co-infected patients and to discuss public health strategies. Methodology: It is a systematic review focused on understanding the main aspects of Covid-19 co-infection and Guillain-Barré Syndrome (GBS). The research was guided by the question: 'What are the biological and immunological mechanisms underlying the interaction between SARS-CoV-2 and GBS and how do they affect susceptibility, disease progression and clinical manifestations of patients?'. To find answers, we searched the PubMed database using four descriptors combined with the Boolean term "AND": Guillain-Barre Syndrome, COVID-19, SARS-CoV-2, and COVID-19 Vaccines. This resulted in 562 articles. 14 articles were selected for analysis. Results: The reviewed evidence shows a significant association between COVID-19 and the development of Guillain-Barré Syndrome (GBS), especially in older men. The pathogenesis suggests that the inflammatory response triggered by COVID-19 may contribute to the emergence of GBS. The infection aggravates respiratory complications in patients with GBS, increasing the need for early ventilation. Immunomodulatory therapies, such as intravenous immunoglobulin (IVIg), are effective and safe in the management of these patients Conclusion:The review highlights the importance of early diagnosis and close clinical monitoring to improve outcomes.
Objetivo: Analisar a complexa interação sinérgica entre o Covid-19 e a Síndrome de Guillain-Barré (SGB), explorando as implicações clínicas e epidemiológicas dessa coinfecção. Busca-se também avaliar os desafios diagnósticos e terapêuticos enfrentados pelos pacientes co-infectados e discutir as estratégias de saúde pública. Metodologia: É uma revisão sistemática focada em entender os aspectos principais da coinfecção de Covid-19 e a Síndrome de Guillain-Barré (SGB). A pesquisa foi guiada pela pergunta: ‘Quais são os mecanismos biológicos e imunológicos subjacentes à interação entre SARS-CoV-2 e SGB e como eles afetam a susceptibilidade, progressão da doença e as manifestações clínicas dos doentes?’. Para encontrar respostas, foram realizadas buscas na base de dados PubMed usando quatro descritores combinados com o termo booleano “AND”:Guillain-Barre Syndrome, COVID-19, SARS-CoV-2 e COVID-19 Vaccines. Isso resultou em 562 artigos. Sendo selecionado 14 artigos para análise. Resultados: As evidências revisadas mostram uma associação significativa entre COVID-19 e o desenvolvimento da Síndrome de Guillain-Barré (SGB), especialmente em homens idosos. A patogênese sugere que a resposta inflamatória desencadeada pela COVID-19 pode contribuir para o surgimento da SGB. A infecção agrava as complicações respiratórias em pacientes com SGB, aumentando a necessidade de ventilação precoce. As terapias imunomoduladoras, como a imunoglobulina intravenosa (IVIg), são eficazes e seguras no manejo desses pacientes Conclusão:A revisão destaca a importância do diagnóstico precoce e do monitoramento clínico rigoroso para melhorar os desfechos.</abstract><doi>10.56238/levv15n39-191</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2177-2789 |
ispartof | Lumen et virtus, 2024-09, Vol.15 (39), p.4091-4101 |
issn | 2177-2789 2177-2789 |
language | por |
recordid | cdi_crossref_primary_10_56238_levv15n39_191 |
source | EZB-FREE-00999 freely available EZB journals |
title | Mecanismos subjacentes à coinfecção entre COVID-19 e síndrome de Guillain-Barré: Susceptibilidade, progressão da doença e impacto clínico – Uma revisão sistemática |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T05%3A58%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mecanismos%20subjacentes%20%C3%A0%20coinfec%C3%A7%C3%A3o%20entre%20COVID-19%20e%20s%C3%ADndrome%20de%20Guillain-Barr%C3%A9:%20Susceptibilidade,%20progress%C3%A3o%20da%20doen%C3%A7a%20e%20impacto%20cl%C3%ADnico%20%E2%80%93%20Uma%20revis%C3%A3o%20sistem%C3%A1tica&rft.jtitle=Lumen%20et%20virtus&rft.au=Milani,%20Bruno%20Henrique&rft.date=2024-09-12&rft.volume=15&rft.issue=39&rft.spage=4091&rft.epage=4101&rft.pages=4091-4101&rft.issn=2177-2789&rft.eissn=2177-2789&rft_id=info:doi/10.56238/levv15n39-191&rft_dat=%3Ccrossref%3E10_56238_levv15n39_191%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |